Related references
Note: Only part of the references are listed.Deep learning for drug response prediction in cancer
Delora Baptista et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis
Jacob G. Scott et al.
LANCET ONCOLOGY (2021)
A Mechanistic DNA Repair and Survival Model (Medras): Applications to Intrinsic Radiosensitivity, Relative Biological Effectiveness and Dose-Rate
Stephen Joseph McMahon et al.
FRONTIERS IN ONCOLOGY (2021)
A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy
Qi-en He et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Dr.VAE: improving drug response prediction via modeling of drug perturbation effects
Ladislav Rampasek et al.
BIOINFORMATICS (2019)
How rapid advances in imaging are defining the future of precision radiation oncology
Laura Beaton et al.
BRITISH JOURNAL OF CANCER (2019)
Mechanistic Modelling of Radiation Responses
Stephen J. McMahon et al.
CANCERS (2019)
Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549
Endang Nuryadi et al.
Oncotarget (2018)
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang et al.
EBIOMEDICINE (2018)
Equivalence Testing for Psychological Research: A Tutorial
Daniel Lakens et al.
ADVANCES IN METHODS AND PRACTICES IN PSYCHOLOGICAL SCIENCE (2018)
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma
Tobin Strom et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Genomic biomarkers for precision radiation medicine
Scott V. Bratman et al.
LANCET ONCOLOGY (2017)
A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset
Bum-Sup Jang et al.
RADIOTHERAPY AND ONCOLOGY (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
A genetic basis for the variation in the vulnerability of cancer to DNA damage
Brian D. Yard et al.
NATURE COMMUNICATIONS (2016)
Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer
Javier F. Torres-Roca et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Orchestrating high-throughput genomic analysis with Bioconductor
Wolfgang Huber et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer
Tobin Strom et al.
RADIOTHERAPY AND ONCOLOGY (2015)
The radiosensitivity index predicts for overall survival in glioblastoma
Kamran A. Ahmed et al.
ONCOTARGET (2015)
A community effort to assess and improve drug sensitivity prediction algorithms
James C. Costello et al.
NATURE BIOTECHNOLOGY (2014)
Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines
John S. Hall et al.
PLOS ONE (2014)
A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway
Jin Meng et al.
ONCOTARGET (2014)
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
Mohamed E. Abazeed et al.
CANCER RESEARCH (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Predicting outcomes in radiation oncology-multifactorial decision support systems
Philippe Lambin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines
Mario Niepel et al.
SCIENCE SIGNALING (2013)
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy
Emil Mladenov et al.
FRONTIERS IN ONCOLOGY (2013)
Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
Han Sang Kim et al.
BMC GENOMICS (2012)
CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
William C. Reinhold et al.
CANCER RESEARCH (2012)
Validation of a Radiosensitivity Molecular Signature in Breast Cancer
Steven A. Eschrich et al.
CLINICAL CANCER RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
David Venet et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Molecular biology: the key to personalised treatment in radiation oncology?
D. G. Hirst et al.
BRITISH JOURNAL OF RADIOLOGY (2010)
SYSTEMS BIOLOGY MODELING OF THE RADIATION SENSITIVITY NETWORK: A BIOMARKER DISCOVERY PLATFORM
Steven Eschrich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Thomas D. Pfister et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen
Sally A. Amundson et al.
CANCER RESEARCH (2008)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Gene expression profiling of in vitro radiation resistance in cervical carcinoma: A feasibility study
D Tewari et al.
GYNECOLOGIC ONCOLOGY (2005)
Share Paper
